Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.50
BATS BZX Real-Time Price
As of 3:50pm ET
 0.00 / 0.00%
Today’s Change
4.60
Today|||52-Week Range
8.63
+26.05%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +86.67% increase from the last price of 7.50.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$3.8M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.51%
 
 
 
 
 
 
Growthannually 22.83%
 
 
 
 
 
 

Sales

Growthquarterly 19.31%
 
 
 
 
 
 
Growthannually 150.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.